Int J Biol Sci 2010; 6(6):546-555. doi:10.7150/ijbs.6.546 This issue Cite
Research Paper
1. BIO5 Institute, and Department of Cell Biology and Anatomy, University of Arizona, Tucson, AZ 85724, USA;
2. Department of Anatomy & Structural Biology, Brain Health and Repair Research Centre, University of Otago, New Zealand;
3. Institute of Neuroscience and Research Center for Mind, Brain and Learning, National Cheng-Chi University, Taipei 116, Taiwan;
4. National Trauma Research Institute, The Alfred Hospital and Medicine Department, Monash University, Melbourne, VIC 3004, Australia;
5. GDDB, NIDDK, National Institutes of Health, Bethesda, MD 20892, USA;
6. School of Biomedical Sciences, Queensland Brain Institute, University of Queensland, Queensland 4072. Australia.
* Equal contribution
SMAD4 acts as the converging point for TGFβ and BMP signaling in heart development. Here, we investigated the role of SMAD4 in heart development using a novel α skeletal muscle actin Cre recombinase (MuCre) transgenic mouse strain. Lineage tracing using MuCre/ROSA26LacZ reporter mice indicated strong Cre-recombinase expression in developing and adult heart and skeletal muscles. In heart development, significant MuCre expression was noted at E11.5 in the atrial, ventricular, outflow tract and atrioventricular canal myocardium, but not in the endocardial cushions. MuCre-driven conditional deletion of Smad4 in mice caused double outlet right ventricle (DORV), ventricular septal defect (VSD), impaired trabeculation and thinning of ventricular myocardium, and mid-gestational embryonic lethality. In conclusion, MuCre mice effectively delete genes in both heart and skeletal muscles, thus enabling the discovery that myocardial Smad4 deletion causes misalignment of the outflow tract and DORV.
Keywords: heart, myogenesis, transforming growth factor beta, SMAD, Marfan syndrome.